newsfilter
← Latest News
Business Wire·

OS Therapies to Present at H.C. Wainright 26th Annual Global Investment Conference

OS Therapies (NYSE:OSTX) ("OS Therapies" or "the Company"), an ADC and Immunotherapy research and clinical-stage biopharmaceutical company, today announced its participation in the H.C. Wainright 26th Annual Global